On the optimal time points for assessing the cortisol response in the high-dose ACTH stimulation test – a literature review
The high-dose ACTH stimulation test is used to assess adrenal insufficiency. Although the test has a rather simple design, many variables in pretest conditions, performing the test and cortisol methods impact the interpretation of the test result, for which rigid cut-offs were previously used. There is growing attention to standardized work-up and using well-standardized analytical methods and assay-specific cortisol cut-offs. There is less consensus on whether post-stimulation serum cortisol concentrations should be measured at 30 minutes (t30) or 60 minutes (t60) or both. Often the same cortisol cut-off is used for measurements at both time points, even though the continuous cortisol response in this time frame suggests using different cut-offs. We reviewed studies describing cortisol measurements at t30 and t60 during the high-dose AST and studied diagnostic accuracy. We noted that cortisol cut-offs should be specific to the assay used and, when using modern assays, lower than the original 500 or 550 nmol/L. When using a single cut-off for t30 and t60, measurements at the t60 time point showed higher specificity. However, when using time point-specific cortisol cut-offs, the specificity of cortisol measurements at t30 or t60 appeared comparable. In conclusion, serum cortisol measurements at t30 and t60 during the high-dose ACTH stimulation test seem equally accurate. A similar performance may be achieved using either time point alone, provided time point and assay-specific cut-offs are used. It should be noted, however, that the results of the high-dose ACTH stimulation test should always be interpreted within the clinical context.
Authors
- Annenienke C. van de Ven (ORCID: https://orcid.org/0009-0009-0977-5690)
- Nienke Ruurdje Biermasz (ORCID: https://orcid.org/0000-0001-5817-3594)
- Jacquelien J Hillebrand (ORCID: https://orcid.org/0000-0002-1161-0301)
- Annemieke C. Heijboer (ORCID: https://orcid.org/0000-0002-6712-9955)
- Karlijn Koops (ORCID: https://orcid.org/0009-0002-8363-5046)
- Michiel N. Kerstens
- Judith MA Emmen
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- University of Groningen (NL)
- Leiden University Medical Center (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Radboud University Medical Center (NL)
- Amphia Ziekenhuis (NL)
- Amsterdam University Medical Centers (NL)
- Amsterdam Gastroenterology Endocrinology Metabolism (NL)
- Amsterdam Reproduction Development (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Journal of Molecular Endocrinology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1530/jme-26-0058
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00